Radisson SAS Hotel, Amsterdam

Rusland 17

1012 CK Amsterdam

The Netherlands

Chair:
    Cornelis van de Velde, MD, PhD
    The Netherlands

Faculty:
    Fabrice André, MD, PhD
    France

    Bella Kaufman, MD
    Israel

    Dirk Kieback, MD, PhD
    Germany

    Antonio Llombart, MD
    Spain

Friday, 16 October 2009
20:00-22:30	Welcome Reception and Buffet Dinner
Saturday, 17 October 2009
08:45-09:00	Welcome, Introduction and Demographics C. van de Velde, MD, PhD B. Pajk, MD
09:00-09:30	Adjuvant Endocrine Therapy in 2009: Incorporating Data from SABCS and St Gallen into Daily Clinical Practice C. van de Velde, MD, PhD
09:30-10:00	Case #1—Adjuvant Endocrine Therapy for a Postmenopausal Patient at Intermediate Risk of Recurrence D. Kieback, MD, PhD
10:00-10:05	Questions and Answers
10:05-10:35	Case #2—Exploring the Role of Non-Anthracycline Regimens in Early Breast Cancer A. Llombart, MD
10:35-10:40	Questions and Answers
10:40-11:00	Break
11:00-11:30	Case #3—The Use of Gene Expression Profiles in Node-Negative Endocrine-Responsive Early Breast Cancer B. Kaufman, MD
11:30-11:35	Questions and Answers
11:35-12:05	Case #4—Perimenopausal Breast Cancer: What is the Optimal Therapy? D. Kieback, MD, PhD
12:05-12:10	Questions and Answers
12:10-12:40	Case #5—Targeted Therapy for HER2 Overexpressing Metastatic Breast Cancer F. André, MD, PhD
12:40-12:45	Questions and Answers
12:45-13:45	Lunch
13:45-14:15	Case #6—Management of Metastatic Breast Cancer with Disease Progression Following Treatment with an Anthracycline and Taxane B. Kaufman, MD
14:15-14:20	Questions and Answers
14:20-14:50	Case #7—Management of Endocrine-Responsive Metastatic Breast Cancer A. Llombart, MD
14:50-14:55	Questions and Answers
14:55-15:25	Case #8—Current Management of Recurrent Triple-Negative Breast Cancer: What’s the Best Approach? F. André, MD, PhD
15:25-15:30	Questions and Answers
15:30	Concluding Remarks C. van de Velde, MD, PhD